MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Prednisone
Related studies linked through entity extraction aliases.
Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent
- Status
- COMPLETED
- Phase
- PHASE4
Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial
- Status
- COMPLETED
- Phase
- PHASE4
Study of Treatment Response on IgG4 Related Disease (IgG4RD)
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis
- Status
- COMPLETED
- Phase
- PHASE3
Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
- Status
- COMPLETED
- Phase
- PHASE4
The Palliative Benefit of Involved-site Radiotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A
- Status
- COMPLETED
- Phase
- PHASE3
Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD
- Status
- TERMINATED
- Phase
- NA
Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone
- Status
- WITHDRAWN
- Phase
- PHASE1
Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide
- Status
- TERMINATED
- Phase
- PHASE2